Friday, July 10, 2026
🇺🇸 FDA

Drug profile · INN

consolidation

consolidation is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 2
Pipeline programs 4
News articles 0
Drug details — consolidation
Class
—
Route
—
Patents
2
Programs
4
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

consolidation is an FDA-listed pharmaceutical active ingredient.

Key facts

INN consolidation

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Search pipeline
  1. GVA + HDAC Consolidation & Gilteritinib Maintenance Phase 2 · First People's Hospital · Acute Myeloid Leukemia
  2. CC-90011-SCLC-001 Phase 1 · Celgene · extensive stage small cell lung cancer
  3. Influence of propofol sedation on memory consolidation and 'working memory' Unknown · First People's Hospital · Memory Impairment
  4. PCNSL-RMTEA Unknown · First People's Hospital · Primary Central Nervous System Lymphoma (PCNSL)

Related patents

Browse patents

  1. US 7244769

    Methods for treating an impairment in memory consolidation

    Expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 6828351

    Methods and compositions for regulating memory consolidation

    Expires Mon Dec 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

What is consolidation?

consolidation is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.